SCHOTT Pharma AG & Co. KGaA (FRA:1SXP)
Germany · Delayed Price · Currency is EUR 23.75
-0.35 (-1.45%)
Aug 1, 2025, 8:52 PM CET
Accolade Market Cap
FRA:1SXP has a market cap or net worth of €3.55 billion as of August 1, 2025. Its market cap has decreased by -26.25% in one year.
Market Cap
3.55B
Enterprise Value
3.74B
Revenue
972.81M
Ranking
n/a
PE Ratio
24.09
Stock Price
$23.75
Market Cap Chart
Since September 28, 2023, FRA:1SXP's market cap has decreased from 4.71B to 3.55B, a decrease of -24.60%. That is a compound annual growth rate of -14.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 3.55B | -6.20% |
| Dec 30, 2024 | 3.79B | -25.12% |
| Dec 29, 2023 | 5.06B | 7.35% |
| Sep 28, 2023 | 4.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 52.71B |
| Merck KGaA | 46.59B |
| Bayer Aktiengesellschaft | 27.63B |
| Fresenius SE & Co. KGaA | 23.64B |
| Fresenius Medical Care AG | 13.05B |
| Sartorius Aktiengesellschaft | 11.85B |
| Fielmann Group AG | 4.65B |
| Carl Zeiss Meditec AG | 4.26B |